Edwards Lifesciences Corp 흥망사

Edwards Lifesciences Corp EW

출처: SEC EDGAR XBRL companyconcept (10-K) · 통화 USD

검증 ✓ 매출·재무 = SEC EDGAR XBRL companyconcept (10-K) 공시원본 (AI 추정 0) ✓ 재무 신호 = 공시 숫자 계산 (AI 아님)

재무 신호 · 공시 숫자 계산 · AI 아님 · 판정 없음

✦ 흥망사

버튼을 누르면 위 공시 숫자에 근거한 흥망사를 생성합니다 — AI 서술, 예측·투자조언 없음.

▾ 데이터 표 보기

연도	매출	영업이익	순이익	자산	부채	FCF	영업이익률	매출 YoY
2008	$1.2B	—	—	—	—	$103M	—	—
2009	$1.3B	—	—	$1.6B	—	$101M	—	▲ 6.8%
2010	$1.4B	—	—	$1.8B	—	$190M	—	▲ 9.5%
2011	$1.7B	—	—	$2B	—	—	—	▲ 16.0%
2012	$1.9B	—	—	$2.2B	—	—	—	▲ 13.2%
2013	$2B	—	—	$2.7B	—	—	—	▲ 7.7%
2014	$2.3B	—	—	$3.5B	—	—	—	▲ 13.6%
2015	$2.5B	—	—	$4.1B	—	$447M	—	▲ 7.4%
2016	$3B	$751M	—	$4.5B	—	$528M	25.3%	▲ 18.8%
2017	$3.4B	$1.1B	—	$5.7B	—	$833M	31.7%	▲ 15.9%
2018	$3.7B	$748M	—	$5.3B	—	$688M	20.1%	▲ 8.4%
2019	$4.3B	$1.1B	—	$6.5B	—	$929M	26.4%	▲ 16.8%
2020	$4.4B	$898M	—	$7.2B	$2.7B	$647M	20.5%	▲ 0.9%
2021	$5.2B	$1.7B	$1.5B	$8.5B	$2.7B	$1.4B	32.3%	▲ 19.3%
2022	$4.5B	$1.5B	$1.5B	$8.3B	$2.5B	$974M	33.6%	▼ 14.7%
2023	$5B	$1.3B	$1.4B	$9.4B	$2.6B	$643M	26.1%	▲ 12.2%
2024	$5.4B	$1.4B	$4.2B	$13.1B	$3B	$290M	25.3%	▲ 8.6%
2025	$6.1B	$1.3B	$1.1B	$13.7B	$3.4B	$1.3B	20.8%	▲ 11.5%